PeptidePedia The community reference

Talk:Semaglutide

Discussion page·5 threads·2 archives

This article is within the scope of the pharmacology working group.
Rated A-class. High traffic; substantive changes to the lead should be raised here first.

This is the discussion page for the article Semaglutide. It is for improving the article: sources, wording, structure, scope and titles. It is not a general discussion forum about the subject, and it is not a place to ask for advice — see Project:Medical disclaimer.

How much detail on research-chemical material?

The final section is longer here than on any other compound article. Given the traffic this page gets from supplier catalogues, is that proportionate or is it scope creep? — ScopeSeverin (talk) 10:22, 30 March 2026 (UTC)

Proportionate. This is the single most copied peptide in the market and the documentation failures described are the ones most often seen on certificates for it. The general treatment is at Certificate of analysis; what is here is compound-specific. — COA_Colwyn (talk) 14:50, 30 March 2026 (UTC)

Agreed, with one caveat: the section must not read as instructions for evaluating a purchase. It currently describes what a document does and does not establish, which is the right side of that line. — DisclosureDido (talk) 09:15, 31 March 2026 (UTC)

Rodent C-cell findings: how should the label contraindication be framed?Resolved

The contraindication is real and belongs in the article. What the article should not do is imply that human risk is established, because it is not. — MTC_Marisol (talk) 13:12, 14 October 2025 (UTC)

Current wording: derived from rodent findings "whose human relevance is unestablished". That states the label and the evidential position separately. — HedgeHedda (talk) 16:40, 14 October 2025 (UTC)

That is exactly right. Neither reassuring nor alarming, just what is known. ✓ Done — MTC_Marisol (talk) 08:55, 15 October 2025 (UTC)

Resolved. This thread is closed. Reopening it is fine if new sources appear; please add a new subsection rather than editing the closed discussion.

Requested move: → Semaglutide (drug)Requested move

Requested move. A move of this page has been proposed below. The question is whether the proposed title is the one a reader would most plausibly search for, per Project:Manual of style.

Proposing a disambiguated title, since the term is also used loosely for compounded and research-chemical preparations that are not this substance. — DisambigDenzil (talk) 10:05, 20 August 2025 (UTC)

Oppose. Those preparations are nominally the same substance; the difference is provenance, not chemistry, and the article covers both. A parenthetical would suggest a distinction that does not exist at the molecular level. — ManualOfStyleMo (talk) 12:44, 20 August 2025 (UTC)

Closing as not moved. See also the separate article at Compounded semaglutide, which covers the provenance question directly. — ConsensusConal (talk) 09:30, 26 August 2025 (UTC)

This page was last edited on 31 March 2026, by DisclosureDido. Text is available under the PeptidePedia Wiki Content Licence (PPCL-BY-SA 4.0).